- Home
- AUTL vs CCIX Comparison
AUTL vs CCIX Comparison
Compare AUTL & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- CCIX
- Stock Information
- Founded
- AUTL 2014
- CCIX 2023
- Country
- AUTL United Kingdom
- CCIX United States
- Employees
- AUTL N/A
- CCIX N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- CCIX
- Sector
- AUTL Health Care
- CCIX
- Exchange
- AUTL Nasdaq
- CCIX Nasdaq
- Market Cap
- AUTL 368.6M
- CCIX 390.8M
- IPO Year
- AUTL 2018
- CCIX 2024
- Fundamental
- Price
- AUTL $1.37
- CCIX $10.61
- Analyst Decision
- AUTL Strong Buy
- CCIX
- Analyst Count
- AUTL 5
- CCIX 0
- Target Price
- AUTL $9.12
- CCIX N/A
- AVG Volume (30 Days)
- AUTL 2.4M
- CCIX 99.5K
- Earning Date
- AUTL 11-12-2025
- CCIX 01-01-0001
- Dividend Yield
- AUTL N/A
- CCIX N/A
- EPS Growth
- AUTL N/A
- CCIX N/A
- EPS
- AUTL N/A
- CCIX 0.28
- Revenue
- AUTL $51,128,000.00
- CCIX N/A
- Revenue This Year
- AUTL $643.50
- CCIX N/A
- Revenue Next Year
- AUTL $108.69
- CCIX N/A
- P/E Ratio
- AUTL N/A
- CCIX $37.49
- Revenue Growth
- AUTL 406.67
- CCIX N/A
- 52 Week Low
- AUTL $1.11
- CCIX $10.04
- 52 Week High
- AUTL $3.45
- CCIX $11.66
- Technical
- Relative Strength Index (RSI)
- AUTL 44.06
- CCIX 45.58
- Support Level
- AUTL $1.23
- CCIX $10.64
- Resistance Level
- AUTL $1.52
- CCIX $10.69
- Average True Range (ATR)
- AUTL 0.11
- CCIX 0.08
- MACD
- AUTL -0.01
- CCIX -0.01
- Stochastic Oscillator
- AUTL 31.76
- CCIX 31.03
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About CCIX Churchill Capital Corp IX Ordinary Shares
Churchill Capital Corp IX is a blank check company.